CacheBy
Thermo Fisher Scientific Human RGS22 Synthetic Peptide
원본

Thermo Fisher Scientific Human RGS22 Synthetic Peptide

상품 한눈에 보기

Human RGS22 단백질의 N-말단 19개 아미노산 서열에 해당하는 합성 펩타이드. PA5-34426 항체의 블로킹 펩타이드로 사용 가능. PBS(pH 7.2), 0.1% BSA, 0.02% sodium azide 함유. -20°C 보관. 연구용으로만 사용.

카테고리
Protein
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
ADRepligen 웨비나PATsmart를 활용한 바이오공정 분석 전략 · 10/7 오전 10시자세히보기
Thermo Fisher Scientific PEP1468 Human RGS22 Synthetic Peptide 50 ug pk판매 단위 pk
재고 확인 필요
195,500원VAT 포함 215,050원

Thermo Fisher Scientific · Thermo Fisher Scientific Human RGS22 Synthetic Peptide

Applications

Control (Ctrl)

  • Assay-dependent

Blocking Assay (BLOCK)

  • Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Class Synthetic
Type Peptide
Conjugate Unconjugated
Form Liquid
Concentration 200 µg/mL
Purification Purified
Storage Buffer PBS, pH 7.2, with 0.1% BSA
Contains 0.02% sodium azide
Storage Conditions -20°C

Product Specific Information

This peptide corresponds to a 19 amino acid sequence near the amino terminus of human RGS22.
PEP-1468 can be used as a blocking peptide with polyclonal antibody PA5-34426.

Target Information

Regulator of G-protein signaling (RGS) proteins contain a conserved 120 amino acid RGS domain that functions as a GTPase-activating protein to reduce signaling from receptor-activated G-alpha subunits.
RGS22 is a recently identified member of this family, localized to the testis, and interacts with guanine nucleotide-binding proteins alpha 11, 12, and 13 (GNA11, GNA12, GNA13).
Although RGS22 is implicated in spermiogenesis, it is also expressed in several epithelial-origin cancer cell lines and associated with cancer metastasis. Overexpression of RGS22 in highly metastatic cancer cells decreases migration and invasiveness, suggesting its potential as a prognostic biomarker for metastasis.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0개

아직 등록된 문의가 없어요.